Latest CF News
Study Sheds Light on Pathology of End-Stage Lung Disease in IPF and CF
High Prevalence of Anxiety and Depression Found Among People With CF
CF Combination Therapy Poorly Tolerated in Lung Transplant Recipients
Patients With CF Show Increased Risk of Drug Hypersensitivity Responses
CF Combination Therapy Improves Sinonasal Quality of Life in Children
Recurrent Airway Infections Predict CF Carrier Status
Novel CRISPR/Cas System May Efficiently Repair Mutations Causing DMD and CF
Chronic Rhinosinusitis Lessens Quality of Life in CF
Study Highlights Need to Manage Sinonasal Symptoms in CF
Proposed Bayesian Method Predicts Ventilation Distribution in CF
Modified APRI Score as a Noninvasive Tool for Diagnosing CFRLD
New Platform Delivers Functional CFTR Protein to Epithelial Cells
PEP More Effective Than Usual Care for Lung Clearance in Cystic Fibrosis
Oxidative Stress Elevated in CF, Increases With Time and Disease Severity
Individualized Approaches Best for Boosting Nutritional Status of Patients With CF
Lung Transplantation Safe and Feasible for CF, Study Says
CF Clinical Trials
Insights
The Challenges of Using Gene Therapy to Treat Respiratory Disease
Researchers are increasingly exploring the potential of gene therapy in treating respiratory diseases.
How Epidemiological Studies Can Help Improve Clinical Outcomes in Cystic Fibrosis
Medical researchers reported on epidemiological data concerning cystic fibrosis, yielding new insights on how to improve clinical outcomes.
The Underrecognized Burden of Sleep‐Disordered Breathing in Cystic Fibrosis
The underdiagnosis and consequent undertreatment of sleep-disordered breathing in the CF population can compromise patients’ overall outcomes.
Changing the Paradigm of Cystic Fibrosis Treatment With CFTR Modulators
Modulators of the cystic fibrosis transmembrane conductance regulator protein have emerged as a promising therapeutic strategy for CF.
The Delicate Task of Targeting Neutrophilic Inflammation in Cystic Fibrosis Lung Disease
Our ability to tackle neutrophilic inflammation while maintaining healthy immune function may be key to tackling cystic fibrosis lung disease.
Patient Perspectives
What My Cystic Fibrosis Care Team Does Right
The other day, I had a follow-up clinic visit for cystic fibrosis. In the waiting room for my pulmonary function tests, I noticed how aggravated I was.
Where My Life With Cystic Fibrosis Began and Where It Leaves Me Now
The goal for my life was tragically simple: I just wanted to celebrate my 21st birthday and then take my last breath.
See Me, the Person, Not Me in My Wheelchair
A lot of people see the wheelchair and automatically assume we can not do anything or they feel sorry for people like us. I do not want anyone to feel sorry for me, because I do not feel sorry for myself.
Cystic Fibrosis Features
Aytu BioPharma’s Healight Device Could Help Treat Rare Pulmonary Diseases
Aytu BioPharma has developed an endotracheal respiratory catheter which its CEO says has “tremendous potential” in IPF, PAH, and other respiratory diseases.
COVID-19 Presents a Low Risk for Most Children With Cystic Fibrosis
Children with cystic fibrosis are at relatively low risk of serious complications from COVID-19, a study sponsored by the Cystic Fibrosis Foundation found.
Using Technology to Boost Ethnic, Geographic Diversity in Clinical Trials
Eliminating geographic and ethnic bias in clinical trials for rare diseases is the goal of Jeeva Informatics, says founder and CEO Harsha K. Rajasimha, PhD.
Israel Emerges as Global Powerhouse in Rare Disease Research
When it comes to rare disorders, Israel—a New Jersey-sized nation of 9.3 million that’s made headlines this year for its highly successful coronavirus vaccination campaign—is clearly an emerging powerhouse.
Rare Care Podcast
- Loading...
Loading...
Loading... 
Loading...